Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ICON Public Limited Company    ICLR   IE0005711209

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ICON plc : to Present at Barclays Global Healthcare Conference 2020

share with twitter share with LinkedIn share with facebook
share via e-mail
03/03/2020 | 09:14am EDT

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at Barclays Global Healthcare Conference 2020 on Tuesday, March 10, 2020. The presentation will be webcast live from 10.15am EDT.

A link to the live webcast will be available via the Investor section of our website under “Events”.

About ICON plc

ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently operates from 97 locations in 40 countries and has approximately 14,650 employees as at December 31, 2019. Further information is available at www.iconplc.com.

This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC's website at http://www.sec.gov.

Source: ICON plc

ICON/ICLR-G


© Business Wire 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ICON PUBLIC LIMITED COMPAN
05/27ICON PLC : to Present at Jefferies Virtual Healthcare Conference
BU
05/13ICON PLC : to Present at UBS Virtual Global Healthcare Conference
BU
05/05ICON PUBLIC : Appoints New Chief Medical Officer
BU
04/22ICON PUBLIC : Reports First Quarter 2020 Results
BU
04/09ICON PUBLIC :  ICON wins multiple categories in 2020 CRO Leadership Awards third..
BU
04/03ICON PUBLIC : Signs New Service Agreement With Pfizer
BU
03/03ICON PLC : to Present at Barclays Global Healthcare Conference 2020
BU
02/19ICON PUBLIC : plc Q4 2019 Presentation.pdf
PU
02/19ICON PUBLIC : Acquires MedPass International
BU
02/19ICON PUBLIC : Reports Fourth Quarter and Full Year 2019 Results
BU
More news
Financials (USD)
Sales 2020 2 682 M
EBIT 2020 366 M
Net income 2020 312 M
Finance 2020 333 M
Yield 2020 -
P/E ratio 2020 28,2x
P/E ratio 2021 21,8x
EV / Sales2020 3,10x
EV / Sales2021 2,70x
Capitalization 8 637 M
Chart ICON PUBLIC LIMITED COMPANY
Duration : Period :
ICON Public Limited Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICON PUBLIC LIMITED COMPAN
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 159,60 $
Last Close Price 164,48 $
Spread / Highest target 10,0%
Spread / Average Target -2,97%
Spread / Lowest Target -24,0%
EPS Revisions
Managers
NameTitle
Stephen A. Cutler Chief Executive Officer & Executive Director
Ciaran Murray Executive Chairman
Brendan Brennan Chief Financial Officer
Tom O'Leary Chief Information Officer
Anthony J. Japour Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
ICON PUBLIC LIMITED COMPANY-4.50%8 637
LONZA GROUP37.54%37 323
IQVIA HOLDINGS INC.-4.98%27 403
SEATTLE GENETICS, INC.33.88%26 258
CELLTRION, INC.17.68%23 280
MODERNA, INC.166.77%22 439